Evaluation of serum alpha fetoprotein-L3 as an accuracy novel biomarker for the early diagnosis of hepatocellular carcinoma in Egyptian patients

BACKGROUND: Most Hepatocellular Carcinomas (HCCs) are diagnosed at an advanced stage. However, HCC early diagnosis is complicated by the coexistence of inflammation and cirrhosis. The unsatisfactory sensitivity and specificity of Alpha-fetoprotien (AFP) for screening of early-stage HCC paved the way...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Hassnaa M., Elghannam, Magdy Z., Elkhawaga, Om Ali Y., El-Sokkary, Ahmed M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459033/
https://www.ncbi.nlm.nih.gov/pubmed/34588888
http://dx.doi.org/10.1016/j.sjbs.2021.06.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459033/
https://www.ncbi.nlm.nih.gov/pubmed/34588888
http://dx.doi.org/10.1016/j.sjbs.2021.06.020

Ejemplares similares